Dose Ranging Study of an Ocular Sirolimus (Rapamycin) Formulation in Patients With Diabetic Macular Edema
Status:
Completed
Trial end date:
2012-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the safety and efficacy of an ocular sirolimus
(rapamycin) formulation at various doses in patients with diabetic macular edema.